Caption Management’s bluebird bio BLUE Stock Holding History

Caption Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,500	Closed	-$152K	–	1351
2023 Q3	$152K	Hold	2,500	–	–	﹤0.01%	1117
2023 Q2	$165K	Buy	+2,500	New	+$183K	﹤0.01%	952
2021 Q3	–	Sell	-9,264	Closed	-$3.84M	–	1517
2021 Q2	$3.84M	Sell	9,264 -13,317	-59%	-$5.28M	0.05%	443
2021 Q1	$8.82M	Buy	+22,581	New	+$11.1M	0.19%	137
2020 Q3	–	Sell	-2,084	Closed	-$1.65M	–	1037
2020 Q2	$1.65M	Hold	2,084	–	–	0.05%	421
2020 Q1	$1.24M	Buy	+2,084	New	+$2.03M	0.07%	348
2019 Q4	–	Sell	-2,779	Closed	-$3.31M	–	827
2019 Q3	$3.31M	Buy	2,779 +1,814	+188%	+$2.77M	0.17%	160
2019 Q2	$1.59M	Sell	965 -965	-50%	-$1.67M	0.08%	295
2019 Q1	$3.93M	Buy	+1,930	New	+$3.4M	0.22%	136

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Caption Management's BLUE Position: Q4 2023 in Review

Caption Management sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 500 shares — an estimated $30.4K sold.

Caption Management first reported a position in BLUE in Q2 2018 and held it in 13 quarters. The position peaked at $2.28M in Q4 2019. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

Caption Management reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
Caption Management sold 500 bluebird bio shares in Q4 2023, an estimated $30.4K.
Caption Management first reported a position in bluebird bio in Q2 2018 and held it in 13 quarters.
Caption Management's bluebird bio position peaked at $2.28M in Q4 2019.
187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Caption Management's 13F filing for Q4 2023, filed 14 Feb 2024.